Contineum Therapeutics (CTNM) Amortizatization of Intangibles (2023 - 2026)
Contineum Therapeutics (CTNM) recorded quarterly Amortizatization of Intangibles of $395000.0 in Q1 2026, up 0.77% quarter-over-quarter from $392000.0 in Q4 2025, and up 69.53% on a YoY basis from $233000.0 in Q1 2025.
Contineum Therapeutics (CTNM) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $395000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 69.53% year-over-year to $395000.0; the TTM figure through Mar 2026 stood at $1.2 million (down 68.39% YoY), while the FY2025 annual figure was $1.1 million, down 72.59% from the prior year.
- Amortizatization of Intangibles was $395000.0 for Q1 2026 at Contineum Therapeutics, up from $392000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.2 million in Q4 2024 to a low of -$4000.0 in Q3 2025.
- Historically, Amortizatization of Intangibles has averaged $622307.7 across 4 years, with a median of $244000.0 in 2024.
- Biggest YoY gain for Amortizatization of Intangibles was 88.11% in 2025; the steepest drop was 101.73% in 2025.
- A 4-year view of Amortizatization of Intangibles shows it stood at $2.0 million in 2023, then surged by 63.17% to $3.2 million in 2024, then slumped by 87.83% to $392000.0 in 2025, then increased by 0.77% to $395000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $395000.0 (Q1 2026), $392000.0 (Q4 2025), and -$4000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Contineum Therapeutics | 423.05 Mn | 423.05 Mn | - | 395,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 395,000.00 |
| Mar 31, 2026 | 395,000.00 |
| Dec 31, 2025 | 392,000.00 |
| Dec 31, 2025 | 392,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | 459,000.00 |
| Jun 30, 2025 | 459,000.00 |
| Mar 31, 2025 | 233,000.00 |
| Mar 31, 2025 | 233,000.00 |
| Dec 31, 2024 | 3.22 Mn |
| Dec 31, 2024 | 3.22 Mn |
| Sep 30, 2024 | 231,000.00 |
| Sep 30, 2024 | 231,000.00 |
| Jun 30, 2024 | 244,000.00 |
| Jun 30, 2024 | 244,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Dec 31, 2023 | 1.97 Mn |
| Dec 31, 2023 | 1.97 Mn |